Cargando…
Type 1 diabetes and engineering enhanced islet transplantation
The development of new therapeutic approaches to treat type 1 diabetes mellitus (T1D) relies on the precise understanding and deciphering of insulin-secreting β-cell biology, as well as the mechanisms responsible for their autoimmune destruction. β-cell or islet transplantation is viewed as a potent...
Autores principales: | Jeyagaran, Abiramy, Lu, Chuan-en, Zbinden, Aline, Birkenfeld, Andreas L., Brucker, Sara Y., Layland, Shannon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers, B.V
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531713/ https://www.ncbi.nlm.nih.gov/pubmed/36002043 http://dx.doi.org/10.1016/j.addr.2022.114481 |
Ejemplares similares
-
Controlled Heterotypic Pseudo-Islet Assembly of Human β-Cells and Human Umbilical Vein Endothelial Cells Using Magnetic Levitation
por: Urbanczyk, Max, et al.
Publicado: (2020) -
Islet Transplantation in Type I Diabetes Mellitus
por: Jamiolkowski, Ryan M., et al.
Publicado: (2012) -
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation
por: Gammon, Joshua M., et al.
Publicado: (2023) -
Leptin Administration Enhances Islet Transplant Performance in Diabetic Mice
por: Denroche, Heather C., et al.
Publicado: (2013) -
Prospects for regenerative medicine approaches in women's health
por: Schenke‐Layland, Katja, et al.
Publicado: (2015)